Visioneering Technologies gains CE mark for NaturalVue 1-day lenses

Visioneering Technologies has received the European CE mark for commercialization in the E.U. for its portfolio of proprietary NaturalVue brand 1-Day Contact Lenses, including sphere, toric, multifocal and multifocal toric, made of etafilcon A.

The CE mark includes an indication for Visioneering Technologies Inc.’s (VTI’s) NaturalVue Multifocal for myopic progression control, according to a press release from the company. The NaturalVue Multifocal for myopic progression lens design allows it to be used for both myopic progression control and presbyopia.

Andrew D. Price, FBDO(Hons) CL, CEO of the ADP Consultancy, said that it is “remarkable” for a company the size of VTI to have developed such a “uniquely powerful, elegant” product, according to the press release.

The CE mark allows VTI to commercialize its contact lens products in Europe as well as to prepare regulatory submissions to launch its products in additional countries, including Australia, New Zealand, Hong Kong and Singapore.

Visioneering Technologies has received the European CE mark for commercialization in the E.U. for its portfolio of proprietary NaturalVue brand 1-Day Contact Lenses, including sphere, toric, multifocal and multifocal toric, made of etafilcon A.

The CE mark includes an indication for Visioneering Technologies Inc.’s (VTI’s) NaturalVue Multifocal for myopic progression control, according to a press release from the company. The NaturalVue Multifocal for myopic progression lens design allows it to be used for both myopic progression control and presbyopia.

Andrew D. Price, FBDO(Hons) CL, CEO of the ADP Consultancy, said that it is “remarkable” for a company the size of VTI to have developed such a “uniquely powerful, elegant” product, according to the press release.

The CE mark allows VTI to commercialize its contact lens products in Europe as well as to prepare regulatory submissions to launch its products in additional countries, including Australia, New Zealand, Hong Kong and Singapore.